EGFR Exon 20 Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations (NCT05241873) | Blueprint Medicines Corporation | 2022-03-04 |
| A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer (NCT04036682) | Cullinan Therapeutics Inc. | 2019-10-31 |
| Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC (NCT03066206) | M.D. Anderson Cancer Center | 2017-03-17 |
Track EGFR Exon 20 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.